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To limit the spread of retroviruses, mammals appear to have tailored a way to inhibit host-to-host infection
by milk-borne retroviruses. In this issue of Cell Host & Microbe, Okeoma et al. (2010) reveal that the host
restriction factor APOBEC3 expressed in mammary endothelial cells inactivates retroviruses released in
maternal milk.Retroviruses have a unique feature that
distinguishes themfrommostotherpatho-
gens: they are capable of permanently
modifying the genome of a host. Added
to this treachery, they can do so very
quickly. Upon entering a cell, a retrovirus
needs only a few hours to reverse-tran-
scribe its RNA genome into double-
stranded DNA and integrate itself into the
genome of the target cell. Adaptive and
innate immune responses aremostly inad-
equate to respond to such a quick assault.
Both these defense systems rely on
sensors to detect a given pathogen, which
in turn activates molecular and cellular
cascades to eliminate the threat. Adaptive
immune responses are further encum-
bered by their requirement to be initially
educated to recognize the specific signa-
ture of a pathogen.
In response to the selective pressure
exerted on their genomes, mammals
have evolved unique mechanisms, gener-
ically called host restriction factors, to
deal with retroviruses (Wolf and Goff,
2008). These factors confer intrinsic
immunity by directly blocking or hindering
the infection cycle of retroviral pathogens
that may or may not have been encoun-
tered before. In humans, there are three
major players that provide intrinsic immu-
nity against retroviruses: CD317 (BST2/
tetherin), which inhibits the release of
budding retroviral particles; TRIM5a,
which disrupts capsid uncoating; and
the APOBEC3 family of cytidine deami-
nases that act during retroviral replication.
APOBEC3 proteins are expressed in all
placental mammals. Whereas humans
and primates encode seven different
APOBEC3 genes, mice have only a single
copy of the gene. APOBEC3F and
APOBEC3G are the two most potentfamily members against retroviruses in
humans. They can convert large numbers
of cytidines into uridines in single-
stranded DNA retroviral replication inter-
mediates, a feature that is shared with
mouse APOBEC3 (reviewed by Chiu and
Greene, 2008). It is by generating these
hypermutations that APOBEC3 proteins
damage and inactivate retroviral DNA
prior to its genomic integration. In addi-
tion, APOBEC3 proteins also have ways
to inhibit retroviral infectivity that do not
rely solely on deamination (Bishop et al.,
2008). For these reasons, restriction may
occur with either the presence or absence
of hypermutations, depending on the
retrovirus and the APOBEC3 proteins
that are involved. In both cases, however,
the single most essential requirement for
APOBEC3-mediated retroviral restriction
is its packaging in sufficient amounts
into retroviral particles. APOBEC3 pro-
teins are recruited into retroviral particles
prior to their release from an infected
cell. It is these captured APOBEC3 pro-
teins that will interfere with the replication
of the retrovirus once it enters a new
target cell. In response, some viruses
have evolved specific ways to avoid
restriction by APOBEC3 proteins. The
best-studied example isHIVand its antag-
onistic accessory protein Vif that prevents
restriction by eliminating APOBEC3G and
APOBEC3F expressed in virus-producing
cells. Vif achieves this by inducing the
ubiquitination of these proteins that leads
to their subsequent proteasomal degra-
dation. HIV-infected cells can therefore
produce APOBEC3-free particles that
are fully infectious.
APOBEC3 enzymes are gatekeepers
expressed in cells at key entry points
used by retroviruses to infect a host.Cell Host & Microbe 8, DHowever, one of the lesser-appreciated
pathways of retroviral transmission
occurs when mammals breastfeed their
young. Maternal breast milk is not only
a rich source of nutrients, proteins, and
hormones, it also contains neutralizing
antibodies and immune cells which give
newborns a head start in battling patho-
gens. Unfortunately, several immune cells
such as lymphocytes, macrophages, and
dendritic cells are also the targets for
retroviruses because many of them
require dividing cells for productive infec-
tion. Very little is currently known about
mother-to-child transmission of retroviral
pathogens through maternal milk and
the immune defenses that are in place to
prevent it. In the present study, Okeoma
and colleagues exploit an APOBEC3-defi-
cient animal infection model to investigate
this important issue, which has broad
implications for both human and animal
health (Okeoma et al., 2010).
The mouse mammary tumor virus
(MMTV) is a betaretrovirus that is trans-
mitted vertically from an infected mother
to her pups through breast milk. Mice
infected with MMTV have a very high
incidence of developing breast cancer.
MMTV-induced oncogenesis is complex.
The infection starts in the gut of exposed
pups where dendritic cells and lympho-
cytes are infected. These immune cells
eventually migrate to mammary glands
where they transmit the virus to suscep-
tible mammary endothelial cells (MECs),
which start to divide during puberty. The
MMTV long-terminal-repeat promoter
contains a glucocorticoid response ele-
ment; therefore, when estrogen and pro-
gesterone levels increase during puberty
and pregnancy, so does the expression
of MMTV RNA.ecember 16, 2010 ª2010 Elsevier Inc. 467
Figure 1. APOBEC3 Restricts MMTV Vertical Transmission and Spread within the Host
(A) APOBEC3 restricts vertical transmission. Foster-nurtured APOBEC3-deficient mice (/) displayed a high incidence of MMTV-related mammary tumors.
Milk produced by infected wild-type (+/+) mice contained fewer and less infectious MMTV particles.
(B) APOBEC3 restricts the spread ofMMTV infection. APOBEC3-deficient and wild-typemice were irradiated and reconstituted with wild-type bonemarrow prior
to infection with MMTV. The tumor incidence was similar in both mice.
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colleagues were the first to establish that
endogenous APOBEC3 expressed in
lymphoid cells has an important role in
reducing MMTV infectivity in mice
(Okeoma et al., 2007). In this current
report, Okeoma et al. (2010) extend our
knowledge of the in vivo activities of this
restriction factor even further by revealing
that APOBEC3 proteins directly inactivate
the infectivity of milk-borne MMTV. The
authors initially make the observation
that APOBEC3-deficient mouse pups,
which have been foster nurtured by an
MMTV-infected mother, develop much
higher infection levels in their spleens
and mammary glands than control468 Cell Host & Microbe 8, December 16, 201mice. These pups also go on to display
a higher incidence of tumors appearing
at earlier ages than wild-type pups
(Figure 1A). Moreover, the authors notice
that milk from APOBEC3-deficient mice
contains higher titers of MMTV and more
infectious particles than the milk from
wild-type mice. These findings are then
explained by a series of well-performed
experiments. Okeoma and colleagues
first show that infected wild-type and
APOBEC3-deficient mice have a similar
breast tumor incidence when first recon-
stituted with the bone marrow from wild-
type mice (Figure 1B). These findings
clearly illustrate that it is the expression
of APOBEC3 in lymphoid cells which0 ª2010 Elsevier Inc.restricts the spread of MMTV infection to
the breast tissue of the host. But a piece
of the restriction puzzle still needed to
be resolved because it is the infected
MECs and not the lymphocytes that are
reportedly the source of MMTV particles
released in breast milk. To investigate
this, the authors analyzed the content
of MMTV purified from mammary tumors
of infected wild-type mice and showed
that significant levels of MEC-derived
APOBEC3 proteins are encapsidated
into MMTV particles. This undoubtedly
explains the lower infectivity of MMTV
found in the milk of wild-type mice.
Through this work, Okeoma and
colleagues now establish that APOBEC3
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expressed in cells of the lymphoid
compartment restricts the spread of the
retroviral infection within the host, and
(2) its expression in MECs reduces the
infectivity of the retroviral particles that
leave a host to infect its offspring.
If APOBEC3 has such an important role
in restricting retroviral infection in mice,
can human APOBEC3 proteins expressed
in MECs also limit the transmission
of milk-borne retroviruses in humans?
Okeoma and colleagues then extend the
results of their work in an attempt to
bridge their MMTV conclusions with that
of milk-borne transmission of HIV infec-
tion in humans. They show that several
APOBEC3 proteins, including APOBEC3F
and APOBEC3G, are well expressed in
human MECs and thus advance the idea
that they may also participate in restrict-
ing milk-borne HIV infection. However, in
contrast to MMTV infection of MECs in
mice, there is currently no solid clinical
evidence that HIV can infect human
MECs, despite claims that these cells do
in fact express the primary HIV receptor
CD4 as well as the necessary coreceptors
CCR5 and CXCR4 (Dorosko and Connor,
2010). Consequently, a role for APOBEC3
proteins in restricting HIV infection in
breast milk is difficult to prove withoutclear evidence that HIV infects MECs.
Nevertheless, there are several other
retroviruses that can infect humans which
could potentially be transmitted through
breast milk and may be restricted by
human APOBEC3 proteins expressed in
MECs.
Notably, there is an ever-increasing
body of evidence reporting that betaretro-
viruses (similar to MMTV), as well as
xenotropic and polytropicmurine gamma-
retroviruses, are being found in human
biopsy samples from diseases such as
prostate cancer, breast cancer, and
primary biliary cirrhosis (Melana et al.,
2010; Silverman et al., 2010). There are
also recent studies reporting that chronic
fatigue syndrome patients exhibit a high
prevalence of infection by mouse gam-
maretroviruses, which can also be de-
tected at low levels in healthy controls
(Lo et al., 2010; Lombardi et al., 2009).
If the detection of these retroviruses
is indeed the result of a bona fide real
world infection by mouse retroviruses,
then the question that remains is whether
APOBEC3 proteins expressed in lympho-
cytes andMECs provide sufficient protec-
tion against the potentialmilk-borne trans-
mission of these pathogens. Thanks to the
unique animal model developed by
Okeoma and colleagues, it will now beCell Host & Microbe 8, Dpossible to start addressing someof these
important issues.REFERENCES
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